Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?

被引:2
|
作者
Basedau, Hauke [1 ]
Ornello, Raffaele [2 ]
Matteis, Eleonora De [2 ]
Davaasuren, Bolortsetseg [3 ]
Kadyrova, Begimai [4 ]
Vuralli, Doga [5 ]
Bozhenko, Myroslav [6 ]
Azizova, Ilaha [7 ]
Bitsadze, Natia [8 ]
Eralieva, Elnura [9 ]
Ashina, Messoud [10 ]
Mitsikostas, Dimos [11 ]
Puledda, Francesca [12 ,13 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany
[2] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy
[3] State Special Servant Hosp Mongolia, Dept Neurol, Ulaanbaatar, Mongolia
[4] Int Univ Kyrgyzstan, Int Higher Sch Med, Dept Special Clin Disciplines, Bishkek, Kyrgyzstan
[5] Gazi Univ, Neurosci & Neurotechnol Ctr Excellence NOROM, Dept Neurol & Algol, Fac Med,Neuropsychiat Ctr, Ankara, Turkiye
[6] Danylo Halytsky Lviv Natl Med Univ, Dept Neurol, Lvov, Ukraine
[7] Neurol Clin New Med Technol, Baku, Azerbaijan
[8] Caucasus Med Ctr, Tbilisi, Georgia
[9] Osh City Clin Hosp, Osh, Kyrgyzstan
[10] Univ Copenhagen, Rigshosp Glostrup, Danish Headache Ctr, Dept Neurol, Copenhagen, Denmark
[11] Natl & Kapidistrian Univ Athens, Aegint Hosp, Dept Neurol Α, Athens, Greece
[12] Kings Coll London, Inst Psychiat Psychol & Neurosci, Headache Grp, Wolfson SPaRC, London, England
[13] Kings Coll London, Inst Psychiat Psychol & Neurosci, Headache Grp, Wolfson SPaRC, Wellcome Fdn Bldg,Denmark Hill Campus West, London SE59PJ, England
关键词
Migraine; contextual effects; placebo; nocebo; headache; DOUBLE-BLIND; TREATMENT EXPECTATIONS; HEADACHE; TRIALS; ERENUMAB; COMMUNICATION; METAANALYSIS; MEDICATION; ANALGESIA; IMPACT;
D O I
10.1177/03331024231218392
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PurposeTreatments in medicine impact individuals beyond their intended effects, due to phenomena such as the placebo and nocebo effects. The placebo effect arises from the positive expectation of a treatment being beneficial, while the nocebo effect stems from the negative expectation of a treatment causing harm. Both in real-world practice and clinical trials, treatments can lead to outcomes unrelated to their intended mechanism of action, which we categorize as placebo and nocebo responses. These responses, combined with the inherent fluctuation in a condition's natural progression, regression to the mean, and random comorbidities, make up a significant part of the therapeutic experience. Particularly in pain management, placebo and nocebo effects play a substantial role. By addressing modifiable contextual factors such as patient expectations, lifestyle choices, and the therapeutic relationship, healthcare providers can enhance the effectiveness of migraine treatments, paving the way for a more comprehensive, individualized approach to patient care. We must also consider non-modifiable factors like personal experiences, beliefs, and information from social media and the internet.ConclusionThis review offers a summary of our current understanding of the placebo and nocebo effects in migraine management.
引用
收藏
页数:12
相关论文
共 14 条
  • [1] Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
    Stark, Catherine
    Stark, Richard
    Limberg, Nicole
    Rodrigues, Julian
    Cordato, Dennis
    Schwartz, Raymond
    Jukic, Robert
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1)
  • [2] Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review
    Blumenfeld, Andrew M.
    Mechtler, Laszlo
    Cook, Lisa
    Rhyne, Christopher
    Jenkins, Brian
    Hughes, Olivia
    Dabruzzo, Brett
    Manack Adams, Aubrey
    Diamond, Merle
    PAIN AND THERAPY, 2024, 13 (06) : 1571 - 1587
  • [3] Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
    Driessen, Maurice T.
    Cohen, Joshua M.
    Patterson-Lomba, Oscar
    Thompson, Stephen F.
    Seminerio, Michael
    Carr, Karen
    Totev, Todor, I
    Sun, Rochelle
    Yim, Erica
    Mu, Fan
    Ayyagari, Rajeev
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01)
  • [4] Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis
    Fernandez-Bravo-Rodrigo, Jaime
    Cavero-Redondo, Ivan
    Luceron-Lucas-Torres, Maribel
    Martinez-Garcia, Irene
    Flor-Garcia, Amparo
    Barreda-Hernandez, Dolores
    Pascual-Morena, Carlos
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 976
  • [5] Acute Migraine Treatment With Rizatriptan in Real World Settings - Focusing on Treatment Strategy, Effectiveness, and Behavior
    Hu, Henry
    Kurth, Tobias
    Cady, Roger
    Santanello, Nancy
    Bigal, Marcelo E.
    HEADACHE, 2009, 49 : S34 - S42
  • [6] Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
    Driessen, Maurice T.
    Cohen, Joshua M.
    Thompson, Stephen F.
    Patterson-Lomba, Oscar
    Seminerio, Michael J.
    Carr, Karen
    Totev, Todor, I
    Sun, Rochelle
    Yim, Erica
    Mu, Fan
    Ayyagari, Rajeev
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01)
  • [7] Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
    Catherine Stark
    Richard Stark
    Nicole Limberg
    Julian Rodrigues
    Dennis Cordato
    Raymond Schwartz
    Robert Jukic
    The Journal of Headache and Pain, 2019, 20
  • [8] Remote electrical neuromodulation (REN) wearable device for adolescents with migraine: a real-world study of high-frequency abortive treatment suggests preventive effects
    Monteith, Teshamae S.
    Stark-Inbar, Alit
    Shmuely, Sharon
    Harris, Dagan
    Garas, Sandy
    Ironi, Alon
    Kalika, Paige
    Irwin, Samantha L.
    FRONTIERS IN PAIN RESEARCH, 2023, 4
  • [9] Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data
    Lanteri-Minet, Michel
    Ducros, Anne
    Francois, Clement
    Olewinska, Elzbieta
    Nikodem, Mateusz
    Dupont-Benjamin, Laure
    CEPHALALGIA, 2022, 42 (14) : 1543 - 1564
  • [10] Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
    Maurice T. Driessen
    Joshua M. Cohen
    Stephen F. Thompson
    Oscar Patterson-Lomba
    Michael J. Seminerio
    Karen Carr
    Todor I. Totev
    Rochelle Sun
    Erica Yim
    Fan Mu
    Rajeev Ayyagari
    The Journal of Headache and Pain, 2022, 23